These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7018502

  • 1. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH, Smith FR, Berns L, Eder HA, Goodman DS.
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [Abstract] [Full Text] [Related]

  • 2. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB, Probstfield JL, Crow LO, Isaacson SO.
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [Abstract] [Full Text] [Related]

  • 3. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB, Bell C, Olson L.
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [Abstract] [Full Text] [Related]

  • 4. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR, Grundy SM.
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [Abstract] [Full Text] [Related]

  • 5. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ, Peters JR, Frantz ID, Hunninghake DB.
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 7. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Apr; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA, Heimann KW.
    S Afr Med J; 1975 Jul 19; 49(31):1252-6. PubMed ID: 168650
    [Abstract] [Full Text] [Related]

  • 9. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
    Fellin R, Baggio G, Briani G, Baiocchi MR, Manzato E, Baldo G, Crepaldi G.
    Atherosclerosis; 1978 Feb 19; 29(2):241-9. PubMed ID: 348207
    [Abstract] [Full Text] [Related]

  • 10. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
    Lithell H, Vessby B, Boberg J, Hellsing K.
    Atherosclerosis; 1980 Oct 19; 37(2):175-86. PubMed ID: 7000089
    [Abstract] [Full Text] [Related]

  • 11. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan 19; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 12. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
    Clifton-Bligh P, Miller NE, Nestel PJ.
    Clin Sci Mol Med; 1974 Dec 19; 47(6):547-57. PubMed ID: 4375013
    [No Abstract] [Full Text] [Related]

  • 13. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL, Schonfeld G, Weidman SW.
    J Lab Clin Med; 1976 Dec 19; 88(6):1008-18. PubMed ID: 186544
    [Abstract] [Full Text] [Related]

  • 14. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA, Chernoff SB, Krehbiel P, Jackson B, DeCoursey S, Taylor H.
    Am J Cardiol; 1984 Jun 01; 53(11):1514-8. PubMed ID: 6375337
    [Abstract] [Full Text] [Related]

  • 15. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM, Mok HY.
    J Lab Clin Med; 1977 Feb 01; 89(2):354-66. PubMed ID: 833472
    [Abstract] [Full Text] [Related]

  • 16. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R, Twelsick F, Oster P, Schellenberg B, Raetzer H, Heuck CC, Schlierf G.
    Monatsschr Kinderheilkd (1902); 1978 Jul 01; 126(7):436-40. PubMed ID: 672910
    [Abstract] [Full Text] [Related]

  • 17. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G, Witztum J, Basich P.
    Artery; 1982 Jul 01; 10(2):99-104. PubMed ID: 7092583
    [Abstract] [Full Text] [Related]

  • 18. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
    Groot PH, Dijkhuis-Stoffelsma R, Grose WF, Ambagtsheer JJ, Fernandes J.
    Acta Paediatr Scand; 1983 Jan 01; 72(1):81-5. PubMed ID: 6407278
    [Abstract] [Full Text] [Related]

  • 19. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM, McCluskey MA, Lees RS.
    Atherosclerosis; 1976 Jan 01; 24(1-2):129-40. PubMed ID: 182181
    [Abstract] [Full Text] [Related]

  • 20. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
    Insull W, Davidson MH, Demke DM, Dujovne CA, Eckert SM, Ginsberg D, Goldberg AC, Hodis HN, Hughes TA, Kane JP.
    Atherosclerosis; 1995 Jan 20; 112(2):223-35. PubMed ID: 7772081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.